PHARMACEUTICALS
Drug maker Ramoliya Pharma announces aggressive nationwide expansion, challenging established pharma giants
SYNOPSIS
Ramoliya Pharma has initiated an assertive nationwide expansion across major Indian pharma hubs, positioning itself as a rising challenger to long-established drug makers such as Alkem, Dr. Reddy’s, Laborate, and Aurobindo. The company is strengthening its branded division, widening distribution, and targeting high-volume territories across North, North East, and South India.
Rising drug maker Ramoliya Pharma has announced a bold, pan-India expansion that places the company in direct competition with some of the country’s most established pharma giants. The move marks a significant shift in the domestic market landscape as the company sharpens its presence across key hubs including Delhi, Uttar Pradesh, Madhya Pradesh, Gujarat and major southern regions.
According to people familiar with the development, Ramoliya Pharma is strengthening its branded portfolio and widening its distribution network with the intention of securing a deeper foothold in high-demand markets. The expansion signals a clear ambition to position the company among the next line of influential players in the sector.
Industry watchers say the scale and speed of the rollout bring Ramoliya Pharma into the competitive orbit of Sun Pharma, Dr. Reddy’s Laboratories, Alkem Laboratories, Aurobindo, Cipla, and other long-standing leaders. The company’s strategic push reflects a broader shift in the Indian drug market.